Evaluation of Newly Developed Combination Therapy of Intra-Arterial 5-Fluorouracil and Systemic Pegylated Interferon α-2B for Advanced Hepatocellular Carcinoma with Portal Venous Invasion

被引：0
|
作者：
Sawara, Kei
Kasai, Kazuhiro
Suzuki, Kazuyuki
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A860 / A860
页数：1
相关论文
共 50 条
  • [41] MULTICENTRIC PHASE II STUDY EVALUATING THE CLINICAL EFFECTS OF INTRA-ARTERIAL COMBINATION THERAPY OF CISPLATIN SUSPENSION IN LIPIODOL AND 5-FLUOROURACIL INFUSION FOR UNRESECTABLE ADVANCED HEPATOCELLULAR CARCINOMA
    Nagamatsu, Hiroaki
    Torimura, Takuji
    Niizeki, Takashi
    Tajiri, Nobuyoshi
    Matsugaki, Satoshi
    Kajiwara, Masahiko
    Iwamoto, Hideki
    Kurogi, Junichi
    Sata, Michio
    HEPATOLOGY, 2010, 52 (04) : 1144A - 1144A
  • [42] A PHASE I/II TRIAL OF CONTINUOUS HEPATIC INTRA-ARTERIAL INFUSION OF 5-FLUOROURACIL, MITOXANTRONE AND CISPLATIN (FMP THERAPY) FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Ikeda, M.
    Okusaka, T.
    Sato, Y.
    Furuse, J.
    Nakachi, K.
    Ueno, H.
    Morizane, C.
    Inaba, Y.
    Satake, M.
    Arai, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 246 - 246
  • [43] Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma
    Munechika Enjoji
    Shusuke Morizono
    Kazuhiro Kotoh
    Motoyuki Kohjima
    Yuzuru Miyagi
    Tsuyoshi Yoshimoto
    Makoto Nakamuta
    World Journal of Gastroenterology, 2005, (36) : 5685 - 5687
  • [44] Re-evaluation of antitumor effects of combination chemotherapy with interferon-α and 5-fluorouracil for advanced hepatocellular carcinoma
    Enjoji, Munechika
    Morizono, Shusuke
    Kotoh, Kazuhiro
    Kohjima, Motoyuki
    Miyagi, Yuzuru
    Yoshimoto, Tsuyoshi
    Nakamuta, Makoto
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (36) : 5685 - 5687
  • [45] Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules
    Nagano, Hiroaki
    Miyamoto, Atsushi
    Wada, Hiroshi
    Ota, Hideo
    Marubashi, Shigeru
    Takeda, Yutaka
    Dono, Keizo
    Umeshita, Koji
    Sakon, Masato
    Monden, Morito
    CANCER, 2007, 110 (11) : 2493 - 2501
  • [46] A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma
    Ikeda, Masafumi
    Okusaka, Takuji
    Sato, Yozo
    Furuse, Junji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Morizane, Chigusa
    Inaba, Yoshitaka
    Kobayashi, Tatsushi
    Arai, Yasuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (06) : 512 - 519
  • [47] A phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone, and cisplatin (FMP therapy) for advanced hepatocellular carcinoma.
    Ikeda, M.
    Okusaka, T.
    Ueno, H.
    Morizane, C.
    Nakachi, K.
    Mitsunaga, S.
    Sato, Y.
    Inaba, Y.
    Satake, M.
    Arai, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Anti-angiogenic effects of combination therapy of interferon-alpha and 5-fluorouracil in the treatment for advanced hepatocellular carcinoma
    Wada, Hiroshi
    Nagano, Hiroaki
    Yamamoto, Hirofumi
    Ota, Hideo
    Nakamura, Masato
    Damdinsuren, Bazarragchaa
    Noda, Takehiro
    Marubashi, Shigeru
    Miyamoto, Atsushi
    Takeda, Yutaka
    Umeshita, Koji
    Dono, Keizo
    Monden, Morito
    HEPATOLOGY, 2006, 44 (04) : 623A - 623A
  • [49] Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
    Sakon, M
    Nagano, H
    Dono, K
    Nakamori, S
    Umeshita, K
    Yamada, A
    Kawata, S
    Imai, Y
    Iijima, S
    Monden, M
    CANCER, 2002, 94 (02) : 435 - 442
  • [50] Surgical adjuvant therapy of rectal carcinoma:: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-α2b
    Gennatas, C
    Dardoufas, C
    Mouratidou, D
    Tsavaris, N
    Pouli, A
    Androulakis, G
    Philippakis, M
    Voros, D
    Batalis, T
    Besbeas, S
    Hatzistylianos, G
    Katsos, J
    Komporozos, V
    Legakis, N
    Mallas, H
    Peros, G
    Photopoulos, A
    Pisiotis, C
    Polymeneas, G
    Retalis, G
    Samanidis, L
    Smyrniotis, V
    Stamatiadis, A
    Vasiliou, J
    Andreadis, H
    Papadimitriou, J
    ANNALS OF ONCOLOGY, 2003, 14 (03) : 378 - 382
12345